BioNexus Gene Lab Corp risk profile
67 Stretched several inputs deteriorating together
Measured 21 October 2026 from BGLC's filed statements. Recomputed nightly.
67 (Stretched), driven by Cash conversion at 100, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 87 | Acute | Volatile | One-year price volatility — 68.7% |
| Operating pressure | 74 | Stretched | Easing | Operating-margin drift — -37.3 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -0.02x |
| Leverage and coverage | 35 | Normal | Stable | Interest cover — -143.12x |
| Competitive position | 56 | Elevated | Stable | Revenue-growth gap against peers — -21.4 percentage points |
| Concentration | 76 | Stretched | Stable | Geographic concentration — 6,300 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Basic Materials companies with a risk reading
Linde Plc. 28BHP Group Ltd 24Industria De Diseno Textil SA 20Southern Copper Corporation 13Rio Tinto Group 40Rio Tinto plc 37Newmont Corp 21L'Air Liquide S.A. 39Freeport-McMoRan Inc 35Agnico Eagle Mines Ltd 10Glencore plc 62Glencore PLC 62
Financials, valuation and price history for BioNexus Gene Lab Corp